Literature DB >> 25824447

Which determinants predict tibiofemoral and patellofemoral osteoarthritis after anterior cruciate ligament injury? A systematic review.

Belle L van Meer1, Duncan E Meuffels1, Wilbert A van Eijsden1, Jan A N Verhaar1, Sita M A Bierma-Zeinstra2, Max Reijman1.   

Abstract

BACKGROUND: Anterior cruciate ligament (ACL) injury is an important risk factor for development of knee osteoarthritis (OA). To identify those ACL injured patients at increased risk for knee OA, it is necessary to understand risk factors for OA. AIM: To summarise the evidence for determinants of (1) tibiofemoral OA and (2) patellofemoral OA in ACL injured patients.
METHODS: MEDLINE, EMBASE, Web of Science and CINAHL databases were searched up to 20 December 2013. Additionally, reference lists of eligible studies were manually and independently screened by two reviewers. 2348 studies were assessed for the following main inclusion criteria: ≥20 patients; ACL injured patients treated operatively or non-operatively; reporting OA as outcome; description of relationship between OA outcome and determinants; and a follow-up period ≥2 years. Two reviewers extracted the data, assessed the risk of bias and performed a best-evidence synthesis.
RESULTS: Sixty-four publications were included and assessed for quality. Two studies were classified as low risk of bias. Medial meniscal injury/meniscectomy showed moderate evidence for influencing OA development (tibiofemoral OA and compartment unspecified). Lateral meniscal injury/meniscectomy showed moderate evidence for no relationship (compartment unspecified), as did time between injury and reconstruction (tibiofemoral and patellofemoral OA).
CONCLUSIONS: Medial meniscal injury/meniscectomy after ACL rupture increased the risk of OA development. In contrast, it seems that lateral meniscal injury/meniscectomy has no relationship with OA development. Our results suggest that time between injury and reconstruction does not influence patellofemoral and tibiofemoral OA development. Many determinants showed conflicting and limited evidence and no determinant showed strong evidence. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ACL; Osteoarthritis

Mesh:

Year:  2015        PMID: 25824447     DOI: 10.1136/bjsports-2013-093258

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  25 in total

Review 1.  [The time-related risk for knee osteoarthritis after ACL injury. Results from a systematic review].

Authors:  G Spahn; M Schiltenwolf; B Hartmann; J Grifka; G O Hofmann; H-T Klemm
Journal:  Orthopade       Date:  2016-01       Impact factor: 1.087

2.  Simple decision rules can reduce reinjury risk by 84% after ACL reconstruction: the Delaware-Oslo ACL cohort study.

Authors:  Hege Grindem; Lynn Snyder-Mackler; Håvard Moksnes; Lars Engebretsen; May Arna Risberg
Journal:  Br J Sports Med       Date:  2016-05-09       Impact factor: 13.800

3.  CORR Insights®: Variations in Knee Kinematics After ACL Injury and After Reconstruction Are Correlated With Bone Shape Differences.

Authors:  Robert Henry Brophy
Journal:  Clin Orthop Relat Res       Date:  2017-06-06       Impact factor: 4.176

4.  Are Bone Bruise Characteristics and Articular Cartilage Pathology Associated with Inferior Outcomes 2 and 6 Years After Anterior Cruciate Ligament Reconstruction?

Authors:  Christian Lattermann; Cale A Jacobs; Emily K Reinke; Erica A Scaramuzza; Laura J Huston; Warren R Dunn; Kurt P Spindler
Journal:  Cartilage       Date:  2016-07-08       Impact factor: 4.634

5.  Every second retired elite female football player has MRI evidence of knee osteoarthritis before age 50 years: a cross-sectional study of clinical and MRI outcomes.

Authors:  Annika Prien; Sana Boudabous; Astrid Junge; Evert Verhagen; Bénédicte M A Delattre; Philippe M Tscholl
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-06-17       Impact factor: 4.342

Review 6.  Satisfactory outcomes following combined unicompartmental knee replacement and anterior cruciate ligament reconstruction.

Authors:  Andrea Volpin; S G Kini; D E Meuffels
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-03-31       Impact factor: 4.342

7.  Time between anterior cruciate ligament injury and reconstruction and cartilage metabolism six-months following reconstruction.

Authors:  Hope C Davis; Jeffery T Spang; Richard F Loeser; Staffan Larsson; Veronica Ulici; J Troy Blackburn; R Alexander Creighton; Ganesh M Kamath; Joanne M Jordan; Stephen W Marshall; Brian Pietrosimone
Journal:  Knee       Date:  2018-03-07       Impact factor: 2.199

8.  Worsening Knee Osteoarthritis Features on Magnetic Resonance Imaging 1 to 5 Years After Anterior Cruciate Ligament Reconstruction.

Authors:  Brooke E Patterson; Adam G Culvenor; Christian J Barton; Ali Guermazi; Joshua J Stefanik; Hayden G Morris; Timothy S Whitehead; Kay M Crossley
Journal:  Am J Sports Med       Date:  2018-09-04       Impact factor: 6.202

9.  Differences in the Lateral Compartment Joint Space Width After Anterior Cruciate Ligament Reconstruction: Data From the MOON Onsite Cohort.

Authors:  Morgan H Jones; Kurt P Spindler; Jack T Andrish; Charles L Cox; Warren R Dunn; Jeff Duryea; Carol L Duong; David C Flanigan; Braden C Fleming; Laura J Huston; Christopher C Kaeding; Matthew J Matava; Nancy A Obuchowski; Heidi L Oksendahl; Richard D Parker; Erica A Scaramuzza; Matthew V Smith; Carl S Winalski; Rick W Wright; Emily K Reinke
Journal:  Am J Sports Med       Date:  2018-02-02       Impact factor: 6.202

10.  Role of thigh muscle cross-sectional area and strength in progression of knee cartilage degeneration over 48 months - data from the Osteoarthritis Initiative.

Authors:  L H Goldman; K Tang; L Facchetti; U Heilmeier; G B Joseph; M C Nevitt; C E McCulloch; R B Souza; T M Link
Journal:  Osteoarthritis Cartilage       Date:  2016-07-25       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.